---
category: news
title: "CellCarta Strengthens its Histological Biomarker Franchise by Acquiring Artificial Intelligence-Based Quantitative Pathology Leader Reveal Biosciences"
excerpt: "CellCarta, a global provider of precision medicine services, announced today the acquisition of Reveal Biosciences (\"Reveal\"), a San"
publishedDateTime: 2021-05-11T21:51:00Z
originalUrl: "https://www.prnewswire.com/in/news-releases/cellcarta-strengthens-its-histological-biomarker-franchise-by-acquiring-artificial-intelligence-based-quantitative-pathology-leader-reveal-biosciences-870266543.html"
webUrl: "https://www.prnewswire.com/in/news-releases/cellcarta-strengthens-its-histological-biomarker-franchise-by-acquiring-artificial-intelligence-based-quantitative-pathology-leader-reveal-biosciences-870266543.html"
type: article
quality: 0
heat: 0
published: false

provider:
  name: PR Newswire
  domain: prnewswire.com

topics:
  - AI

images:
  - url: "https://mma.prnewswire.com/media/1507305/CellCarta_CellCarta_Strengthens_its_Histological_Biomarker_Franc.jpg?p=facebook"
    width: 5157
    height: 2699
    isCached: true

secured: "CzynglMBjVPvzftYZrRunCoxBT1f56NwNxb3zOeXGJsR/4kl+0YzowzOfGeh3OPXGvnW/5Va1LJ50OgfEoQ2N0to2JsYzmapXgwTk8LUFlHqRzqAbRTTXGaeQT+p6pfhbKjz286S8Av9PIDCOEgNsiczOOIaNASi+WJTizE5vOIQksaFkwhtAzqiCIiHd41nxQS3KIIqyiNPa3wYlCohgLoKH773fzVY+D8BGqYs8WaNjeqol+IQ1e6uOUXuF633w/jyis23iOrK3CwnSRwTqR9Yml28qQbX8pctriX9JN637W0AFaMR/Dplr8/tFl+XbGgihLiIKODH/ttGnsmF7DFpILJcZEw09H2COiblxZE=;CoeWulS/WHr/gkfWZWjrow=="
---

